key: cord-0813412-set2ff8g
authors: Liu, Tao; Zeng, Guang; Tao, Huangheng; Shi, Yue; Wang, Ting; Liu, Tongzu; Guo, Fangjian; Zhou, Fuling; Wang, Xinghuan
title: Low prevalence of IgG antibodies to SARS‐CoV‐2 in cancer patients with COVID‐19
date: 2020-06-11
journal: Int J Cancer
DOI: 10.1002/ijc.33148
sha: 2d6895e24d47685cd107a1246816aea2252083fc
doc_id: 813412
cord_uid: set2ff8g

nan

The sponsors had no role in the design and conduct of the study; collection,

This article is protected by copyright. All rights reserved. management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript, and decision to submit the manuscript for publication.

The authors have no conflict of interest to disclose.

The data that support the findings of this study are available from the corresponding authors upon reasonable request.

The study was approved by the institutional ethics board at Zhongnan Hospital of Wuhan University. Requirement for written informed consent was waived by the institutional ethics board. 

This article is protected by copyright. All rights reserved. Accepted Article

Virological assessment of hospitalized patients with COVID-2019

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Antibody responses to SARS-CoV-2 in patients with COVID-19

Connecting clusters of COVID-19: an epidemiological and serological investigation

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China

Effect of Changing Case Definitions for COVID-19 on the Epidemic Curve and Transmission Parameters in Mainland China: A Modelling Study. The Lancet Public health

Antibodies in Infants Born to Mothers With COVID-19 Pneumonia

Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis